Combination Therapy of Topical Imiquimod Plus Multipeptide Vaccination for Cutaneous Metastases of Melanoma.

Trial Profile

Combination Therapy of Topical Imiquimod Plus Multipeptide Vaccination for Cutaneous Metastases of Melanoma.

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Dec 2016

At a glance

  • Drugs Cancer vaccine (Primary) ; Imiquimod (Primary) ; Montanide ISA-51
  • Indications Cancer metastases; Malignant melanoma
  • Focus Adverse reactions
  • Most Recent Events

    • 15 Dec 2016 Status changed from suspended to completed.
    • 20 Sep 2013 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
    • 29 Jun 2012 Planned End Date changed from 1 Jun 2012 to 1 Jun 2015 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top